Table Name: `per_visit`
Description: Clinical data obtained from each visit made by a patient. Each patient has multiple visits throughout the treatment journey and  results for each visit are recorded here. If column description is missing, avoid using it unless explicitly asked to.
column_number | column_name | column_description
1   public_id	Index column. Patient public identifier. Last 4 digits are unique. e.g. MMRF_1234
2   spectrum_seq	Ignore this column
3   visit	A unique number assigned to the visit. e.g. 1 means first visit at which diagnosis was made.
4   vj_interval	Record Interval
5   visitdy Day of Visit counting from day of diagnosis
--After treatment checkup--
6	at_definitedevel	"Checked" means yes
7	at_wasanassessme	Was an assessment of treatment response performed since the last study visit?
8	at_responseasses	Day (since baseline) the response assessment was done.
9	at_treatmentresp	Treatment Response
10	at_increaseof25f	"Checked" means yes
11	at_serummcompone	"Checked" means yes	
12	at_urinemcompone	"Checked" means yes	
13	at_onlyinpatient	"Checked" means yes
14	at_onlyinpatient2	"Checked" means yes
15	at_developmentof	"Checked" means yes
--Bone assessment--
16	ba_wasaboneasses	Was a bone assessment done since the last study visit?
17	ba_dayofassessm	Date of assessment
18	ba_typeofboneass	Type of bone assessment. Unstructured field.
19	ba_specify	Other bone assessment, specify. Unstructured field.
20	ba_imageinterpre	Clinical interpretation of bone assessment. Categorized as normal/clinically significant/clinically insignificant abnormality, is abnormality related or unrelated to MM.
21	ba_lyticlesions	Were there lytic Lesions? "Checked"/"checked" means yes.
22	ba_oflyticlesion	Number of Lytic Lesions. Ordinal categories: "0", "1", "2", or ">=3"
23	ba_osteopeniaost	Osteopenia / Osteoporosis. "checked" means yes.
24	ba_pathologicfra	Pathologic fracture. "checked" means yes.
25	ba_multipledisse	Multiple disseminated lesions. "checked" means yes.
26	ba_skull	Bone lesion in Skull
27	ba_spine	Bone lesion in Spine
28	ba_cervical	Bone lesion in Cervical
29	ba_thoracic	Bone lesion in Thoracic
30	ba_lumbar	Bone lesion in Lumbar
31	ba_sacral	Bone lesion in Sacral
32	ba_pelvis	Bone lesion in Pelvis
33	ba_right	Bone lesion in Right region 1
34	ba_left	Bone lesion in Left region 2
35	ba_femur	Bone lesion in Femur
36	ba_right2	Bone lesion in Right region 2
37	ba_left2	Bone lesion in Left region 2
38	ba_humerus	Bone lesion in Humerus
39	ba_right3	Bone lesion in Right region 3
40	ba_left3	Bone lesion in Left region 3
41	ba_ribs	Bone lesion in Ribs
42	ba_right4	Bone lesion in Right region 4
43	ba_numberaffecte	Number of ribs affected (right side)
44	ba_left4	Bone lesion in Left region 4
45	ba_numberaffecte2	Number of ribs affected (leftt side)
46	ba_other	Bone lesion in Other
47	bb_specify	Specify for BA_OTHER
48	bb_reasonforproc	Reason for procedure
49	bb_cellularity2	
50	bb_percentofplas	Percent of plasma cells
51	bb_wasabonemarro	Was a bone marrow biopsy performed since the last study visit?
52	bb_dayofcollect	Date of collection
53	bb_wasbiopsyspec	Was biopsy specimen adequate for cellularity?
54	bb_ifnopleasespe	If biopsy specimen not adequate for cellularity, specify
55	bb_cellularity	
--Bone marrow aspirate--
56	bone_wasabonemarro	Was a bone marrow aspirate performed since the last study visit?
57	bone_dayofcollect	BMA date of collection
58	bone_wasbonemarrow	Was bone marrow sample sent to the Spectrum Health?
59	bone_volumeofbmasp	
60	bone_plasmaunk	Volume of BMA unknown
61	bone_bmavolumesent	
62	bone_bmaunk	Volume of bma sent to CoMMpass Central Lab unknown
63	bone_wasperipheral	Was peripheral blood sent to the Spectrum Health?
64	bone_dayofcollect2	
65	bone_pc6	BMA: (%PC positive for CD138 by IHC) - reported as %PC
66	bone_percentofplas	BMA: (%PC positive for CD138 by IHC) - %PC
67	bone_reasonforproc	
68	bone_specify2	Other reason for procedure, specify
69	bone_percentofplas3	
70	bone_reportedasper	BMA: Reported as %PC by cytomorphology (smear)
71	bone_rangeofplasma2	BMA: (%PC positive for CD138 by IHC) - reported as %PC range
72	bone_rangelow	BMA: (%PC positive for CD138 by IHC) -  %PC low end of range
73	bone_rangehigh	BMA: (%PC positive for CD138 by IHC) - %PC high end of range
74	bone_rangeunk	BMA: (%PC positive for CD138 by IHC) - not done/unknown
75	bone_bcytomorpholo	
76	bone_pc7	BMA: (%PC by cytomorphology (smear)) - reported as %PC
77	bone_pc2	BMA: (%PC by cytomorphology (smear)) - %PC
78	bone_rangeofplasma3	BMA: (%PC by cytomorphology (smear)) - reported as %PC range
79	bone_rangelow2	BMA: (%PC by cytomorphology (smear)) -  %PC low end of range
80	bone_rangehigh2	BMA: (%PC by cytomorphology (smear)) - %PC high end of range
81	bone_fcaunk	BMA: (%PC by cytomorphology (smear)) - not done/unknown
82	bone_aflowcytometr	BMA: Reported as %cells positive by flow cytometry(FLOW)
83	bone_pc8	BMA: (%cells positive by FLOW) - reported as %PC
84	bone_reportedbycyt	BMA: (%cells positive by FLOW) - %PC
85	bone_rangeofplasma4	BMA: (%cells positive by FLOW) - reported as %PC range
86	bone_rangelow3	BMA: (%cells positive by FLOW) -  %PC low end of range
87	bone_rangehigh3	BMA: (%cells positive by FLOW) - %PC high end of range
88	bone_unknown	BMA: (%cells positive by FLOW) - not done/unknown
89	bone_pc	"checked" means yes.
90	bone_reportedasper2	PC in clot section or BM biopsy: Reported as %PC positive for CD138 by IHC
91	bone_pc9	PC in clot section or BM biopsy: (%PC positive for CD138 by IHC) - reported as %PC
92	bone_pc3	PC in clot section or BM biopsy: (%PC positive for CD138 by IHC) - %PC
93	bone_rangeofplasma5	PC in clot section or BM biopsy: (%PC positive for CD138 by IHC) - reported as %PC range
94	bone_rangelow4	PC in clot section or BM biopsy: (%PC positive for CD138 by IHC) -  %PC low end of range
95	bone_rangehigh4	PC in clot section or BM biopsy: (%PC positive for CD138 by IHC) - %PC high end of range
96	bone_lowvalue	PC in clot section or BM biopsy: (%PC positive for CD138 by IHC) - not done/unknown
97	bone_reportedasper3	PC in clot section or BM biopsy: Reported as %PC by cytomorphology (smear)
98	bone_pc10	PC in clot section or BM biopsy: (%PC by cytomorphology (smear)) - reported as %PC
99	bone_pc4	PC in clot section or BM biopsy: (%PC by cytomorphology (smear)) - %PC
100	bone_rangeofplasma6	PC in clot section or BM biopsy: (%PC by cytomorphology (smear)) - reported as %PC range
101	bone_rangelow5	PC in clot section or BM biopsy: (%PC by cytomorphology (smear)) -  %PC low end of range
102	bone_rangehigh5	PC in clot section or BM biopsy: (%PC by cytomorphology (smear)) - %PC high end of range
103	bone_highvalue	PC in clot section or BM biopsy: (%PC by cytomorphology (smear)) - not done/unknown
104	bone_rangeofplasma	PC in clot section or BM biopsy: Reported as %cells positive by flow cytometry(FLOW)
105	bone_pc11	PC in clot section or BM biopsy: (%cells positive by FLOW) - reported as %PC
106	bone_pc5	PC in clot section or BM biopsy: (%cells positive by FLOW) - %PC
107	bone_rangeofplasma7	PC in clot section or BM biopsy: (%cells positive by FLOW) - reported as %PC range
108	bone_rangelow6	PC in clot section or BM biopsy: (%cells positive by FLOW) -  %PC low end of range
109	bone_rangehigh6	PC in clot section or BM biopsy: (%cells positive by FLOW) - %PC high end of range
110	bone_notdoneunknow	PC in clot section or BM biopsy: (%cells positive by FLOW) - not done/unknown
111	bone_doesthepcresu	Does the %PC result reported above apply to BMA specimen taken at the same time as the specimen submitted to CoMMpass Central Lab
--Bone marrow transplant--
112	bmt_wasabonemarro	Was a bone marrow transplant performed?
113	bmt_dayoftranspl	Date of transplant
114	bmt_autologous	Autologous transplant
115	bmt_allogenic	Allogenic transplant
116	bmt_pleasespecify	Type of allogenic transplant
117	bmt_specify	Type of allogenic transplant
118	bmt_stemcells	Transplant involves Stem cells
119	bmt_bonemarrow	Transplant involves Bone marrow
120	bmt_number	Single transplant or tandem (double-auto) transplant - within a few months of each other.
121	ecog_performancest	ECOG Performance Status. A numerical scale from 0-5 to assess patient's functional capacity and daily living ability.
122	ecog_wasanecogasse	Was an ECOG assessment performed since the last study visit?
123	ecog_assessmentdat	Assessment Date of ECOG
124	ic_dayofinforme	Date of Informed Consent
125	ic_dayofvisit	Date of visit
126	ic_dayuniversal	Date Universal Consent signed
127	ic_didthepatient	Did the patient meet all eligibility requirements for this study?
128	ic_hasthepatient	The patient has signed the Universal Informed Consent
129	ic_ifyespleasepr	If yes, please provide Date of Informed Consent
130	ic_involvedfreel	Involved free light chain level &#8805; 10 mg/dl and an abnormal serum free light chain ratio (<0.26 or >1.65)
131	ic_ipermitmysamp	I permit my Samples and correlating health information to be stored at the MMRF Longitudinal Study Biobank and MMRF Databank, respectively, and used by the MMRF, other organizations and researchers fo
132	ic_ipermitmysamp2	I permit my Samples and correlating health information to be used by the MMRF, other organizations and researchers in the Study and future research to learn about, prevent, or treat any other disorder
133	ic_ipermitresear	I permit researchers at the facility to contact me in the future for an update on my status, or to discuss potential studies which may be appropriate for me
134	ic_nomorethan30d	No more than 30 days from baseline bone marrow evaluation as per this protocol to initiation of first-line therapy.
135	ic_othreason	Other reason for ineligibility?
136	ic_participatepss	Has the patient agreed to participate in the Patient Support Services
137	ic_patienthadano	Patient had another malignancy within the last 5 years (except for basal or squamous cell carcinoma, or in situ cancer of the cervix).
138	ic_patienthasrea	Patient has read, understood and signed informed consent.
139	ic_patientisalre	Patient is already receiving systemic therapy for MM (a single dose of bisphosphonates and up to 100 mg total dose of dexamethasone or equivalent corticosteroids are permitted prior to registration on
140	ic_patientisatle	Patient is at least 18 years old
141	ic_patientisenro	Patient is enrolled in a blinded clinical trial for the first-line treatment of multiple myeloma. Patients may be enrolled in subsequent clinical trials as long as continued access to data and tissue,
142	ic_serummprotein	Serum M protein &#8805; 1g/dl IC_THEPATIENTISA="The patient is a candidate for systemic therapy that includes anIMiD® (e.g., lenalidomide, pomalidomide, thalidomide) and/orproteasome inhibitor (e.g., bortezomib, carfilzomib) as part of theinitia"
143	ic_thepatientisa	The patient is a candidate for systemic therapy that includes an IMiDÂ® (e.g., lenalidomide, pomalidomide, thalidomide) and/or proteasome inhibitor (e.g., bortezomib, carfilzomib) as part of the initia
144	ic_urinemprotein	Urine M protein &#8805; 200 mg/24 hrs
145	ic_wasthispatien2	Was this patient previously consented for this study?
--Surgery--
146	mmsurg_specify	Other multiple myeloma surgery, specify
147	mmsurg_none	No multiple myeloma surgery
148	mmsurg_vertebroplast	Vertebroplasty
149	mmsurg_kyphoplasty	Kyphoplasty
150	mmsurg_other	Other multiple myeloma surgery
--Peripheral nerve neuropathy--
151	pn_wasaneurologi	Was a neurologic assessment performed since the last study visit?
152	pn_assessmentdat	Peripheral neuropathy assessment date
153	pn_peripheralsen	Peripheral sensory neuropathy present?
154	pn_ifyesindicate	If peripheral sensory neuropathy, indicate grade
155	pn_peripheralmot	Peripheral motor neuropathy present?
156	pn_ifyesindicate2	If peripheral motor neuropathy, indicate grade
157	se_causeofdeath	Cause of Death
158	se_dayofdeath	Date of Death
159	se_daypatientco	
160	se_didpatientcom	Did patient complete the study?
161	se_lastknownday	Last known date alive
162	se_primaryreason	Primary Reason for Discontinuation
163	se_specify	Specify
164	se_specify2	Specify
165	supp_anticoagulati	Anticoagulation
166	supp_none	None
167	supp_transfusion	Transfusion
168	supp_packedredbloo	Packed red blood cells
169	supp_platelets	Platelets
170	supp_other	Other
171	supp_specify	Other supportive therapy, specify
172	supp_radiotherapy	Radiotherapy
173	supp_specifysite	Specify site of radiotherapy
174	supp_dialysis	Dialysis
175	supp_bisphosphonat	Bisphosphonates or other bone-directed therapy
176	supp_wbcgrowthfact	WBC growth factors
177	supp_erythropoiesi	Erythropoiesis stimulating agent
178	supp_antiemetic	Antiemetic
179	supp_analgesicsfor	Analgesics for bone pain
180	supp_opioid	Opioid
181	supp_other2	Other
182	supp_antiviral	Antiviral
183	supp_medicationsfo	Medications for neuropathic pain
184	supp_medicationsfo2	Medications for tumor lysis syndrome
185	ss_isthepatientr	Is the patient returning for their regular scheduled follow-up?
186	ss_dayofvisit	Date of Visit
187	ss_doesthepatien	Does the patient have evidence of symptomatic myeloma related to organ damage, tissue impairments or other symptoms?
188	ss_spinalcordcom	Spinal cord compression
189	ss_bonepain	Bone pain
190	ss_fatigue	Fatigue
191	ss_hypercalcemia	Hypercalcemia (corrected calcium > 11.5 mg/dl)
192	ss_renalinsuffic	Renal insufficiency attributable to myeloma
193	ss_anemiahemoglo	Anemia (hemoglobin <10 g/dL)
194	ss_bonelesionsly	Bone Lesions - Lytic Lesions
195	ss_bonelesionsos	Bone Lesions - Osteoporosis with compression fractures
196	ss_softtissuepla	Soft Tissue Plasmacytoma - Single
197	ss_ofttissueplas	Soft Tissue Plasmacytoma - Multiple
198	ss_recurrentbact	Recurrent bacterial infections
199	ss_symptomatichy	Symptomatic hyperviscosity
200	ss_amyloidosis	Amyloidosis
201	ss_other	Other
202	ss_specify	Specify
203	st_plasmacytoman	Plasmacytoma number
204	st_increaseinnum	Was there an increase in Number
205	st_plasmacytoman2	Plasmacytoma number
206	st_resultofexami2	Result of examination
207	st_wasanassessme	Was an assessment for soft tissue plasmacytomas performed since the last study visit?
208	st_assessmentdat	Date of soft tissue plasmacytoma assessment
209	st_wereanysoftti	Were any soft tissue plasmacytomas present during this exam?
210	st_numberofplasm	Number of plasmacytomas
211	st_wasthereachan	Was there a change in Plasmacytomas since last visit
212	st_increaseinsize	Was there an increase in Size
213	st_resultofexami	Result of Examination
--Immunohistochemistry results--
214	d_im_dcl_patient_id	Public Patient ID
215	d_im_collection_day	Collection Date
216	d_im_processing_day	Processing Date
217	d_im_patients__mmrf_eligibility	MMRF Eligibility Status
218	d_im_igh_site	IGH Site
219	d_im_igl_site	IGL Site
220	d_im_morphology_percent_pc_in_bm	Morphology %PC in bone marrow
221	d_im_flowcyt_pct_pc_in_bm_low	Flow cytometer %PC in bone marrow-Low
222	d_im_flowcyt_pct_pc_in_bm_high	Flow cytometer %PC in bone marrow-High
223	d_im_morphology_percent_pc_in_pb	Morphology %PC in peripheral blood
224	d_im_flowcyt_pct_pc_in_pb_low	Flow cytometer %PC in peripheral blood-Low
225	d_im_flowcyt_pct_pc_in_pb_high	Flow cytometer %PC in peripheral blood-High
226	d_im_cd38_detected	CD38 Detected
227	d_im_cd38_pc_percent	CD38 PC%
228	d_im_cd38_description	CD38 Description
229	d_im_cd138_detected	CD138 Detected
230	d_im_cd138_pc_percent	CD138 PC%
231	d_im_cd138_description	CD138 Description
232	d_im_cd45_pc_typical_detected	CD45 PC Typical Detected
233	d_im_cd45_pc_percent	CD45 PC%
234	d_im_cd45_description	CD45 Description
235	d_im_cd56_detected	CD56 Detected
236	d_im_cd56_pc_percent	CD56 PC%
237	d_im_cd56_description	CD56 Description
238	d_im_cd13_detected	CD13 Detected
239	d_im_cd13_pc_percent	CD13 PC%
240	d_im_cd19_detected	CD19 Detected
241	d_im_cd19_pc_percent	CD19 PC%
242	d_im_cd20_detected	CD20 Detected
243	d_im_cd20_pc_percent	CD20 PC%
244	d_im_cd27_detected	CD27 Detected
245	d_im_cd27_pc_percent	CD27 PC%
246	d_im_cd28_detected	CD28 Detected
247	d_im_cd28_pc_percent	CD28 PC%
248	d_im_cd33_detected	CD33 Detected
249	d_im_cd33_pc_percent	CD33 PC%
250	d_im_cd52_detected	CD52 Detected
251	d_im_cd52_pc_percent	CD52 PC%
252	d_im_cd81_detected	CD81 Detected
253	d_im_cd81_pc_percent	CD81 PC%
254	d_im_cd117_detected	CD117 Detected
255	d_im_cd117_pc_percent	CD117 PC%
256	d_im_cd319_detected	CD319 Detected
257	d_im_cd319_pc_percent	CD319 PC%
258	d_im_fgfr3_char	FGFR3 (character)
259	d_im_fgfr3_pc_percent	FGFR3 PC%
260	d_im_light_chain_by_flow	Light Chain by Flow
261	d_im_flowcyt_pct_aneuploid_popul	Flow cytometer %aneuploidy population
262	d_im_dna_index	DNA Index
263	d_im_braf_status	BRAF Status
264	d_im_braf_cdna_variant	BRAF CDNA Variant
265	d_im_braf_protein_variant	BRAF Protein Variant
266	d_im_fgfr3_detected	FGFR3 Detected
267	d_im_visitseq	Sample sequence
268	d_im_cd38des	CD38 Description(coded)
269	d_im_cd56des	CD56 Description(coded)
270	d_im_cd138des	CD138 Description(coded)
271	d_im_cd45d	CD45 Description(coded)
272	d_im_igh	IGH Site(coded)
273	d_im_igl	IGl Site(coded)
274	d_im_lightc	Light Chain by Flow(coded)
275	d_im_aneupgp	Aneuploidy group code
276	d_im_mrgday	Collection or Processing Date
277	d_im_bone_reasonforproc	Reason for procedure reported on CRF
278	d_im_bone_specify2	Reason for procdure on CRF, specify
279	d_im_pddt	Correlated disease progression date
280	d_im_crdt	Correlated Cr/sCR date
281	d_im_enr	Enrollment population flag
282	d_im_reason	Derived reason for sample
283	d_im_crdiff	Days away from closest CR/sCR date
284	d_im_pddiff	Days away from closest PD date
285	d_im_det_plasma_cells	Flag for detectable plasma cells (%PC in BM High > 0)
286	d_im_detectable	Flag for at least one CD marker detected
287	d_im_kaplam	Light chain either kappa or lambda
288	d_im_crhit	Flag for an acceptable sample for CR
289	d_im_pdhit	Flag for an acceptable sample for PD
290	d_im_hit	Flag for an acceptable sample
--Laboratory biochemistry values--
291	d_lab_cbc_abs_neut	Absolute Neutrophil count x10^9/L
292	d_lab_chem_albumin	Albumin (g/L)
293	d_lab_chem_bun	Blood Urea Nitrogen (mmol/L)
294	d_lab_chem_calcium	Calcium (mmol/L)
295	d_lab_chem_creatinine	Serum Creatinine (umol/L)
296	d_lab_chem_glucose	Glucose (mmol/L)
297	d_lab_cbc_hemoglobin	Hemogobin (mmol/L
298	d_lab_serum_kappa	Serum Kappa (mg/dL)
299	d_lab_chem_ldh	LDH (ukat/L)
300	d_lab_serum_m_protein	Serum M Protein (g/dL)
301	d_lab_cbc_platelet	Platelet count x10^9/L
302	d_lab_chem_totprot	Total Protein (g/dL)
303	d_lab_cbc_wbc	White Blood Count  x10^9/L
304	d_lab_serum_iga	Serum IgA (g/L)
305	d_lab_serum_igg	Serum IgG (g/L)
306	d_lab_serum_igm	Serum IgM (g/L)
307	d_lab_serum_beta2_microglobulin	Beta 2 Microglobulin (mcg/mL)
308	d_lab_serum_lambda	Serum Lambda (mg/dL)
309	d_lab_urine_24hr_m_protein	24 hr Urine M Protein (g/24 hr)
310	d_lab_urine_24hr_total_protein	24 hr Urine Total Protein (g/24 hr)
311	d_lab_serum_c_reactive_protein	C-Reactive Protein (mg/dL)
312	d_lab_serum_igd	Serum IgD (mg/L)
313	d_lab_serum_ige	Serum IgE (mg/L)
--Quality of life questionnaire--
314	d_qol_qlq_my20	Was EORTC QLQ-MY20 questionnaire completed at this visit?
315	d_qol_qol_dy	
316	d_qol_qlq_c30	Was EORTC QLQ-C30 questionnaire completed at this visit?
317	d_qol_mpf2	Mean of Physical functioning Questions
318	d_qol_pf2	Physical functioning
319	d_qol_mrf2	Mean of Role functioning Questions
320	d_qol_rf2	Role functioning
321	d_qol_mef	Mean of Emotional functioning Questions
322	d_qol_ef	Emotional functioning
323	d_qol_mcf	Mean of Cognitive functioning Questions
324	d_qol_cf	Cognitive functioning
325	d_qol_msf	Mean of Social functioning Questions
326	d_qol_sf	Social functioning
327	d_qol_mmyfp	Mean of Future perspective Questions
328	d_qol_myfp	Future Perspective
329	d_qol_mmybi	Mean of Body image Questions
330	d_qol_mybi	Body Image
331	d_qol_mql2	Mean of QL2 Questions
332	d_qol_ql2	Global Health Status - QOL
333	d_qol_mfa	Mean of Fatigue Questions
334	d_qol_fa	Fatigue
335	d_qol_mnv	Mean of Nausea and Vomiting Questions
336	d_qol_nv	Nausea and vomiting
337	d_qol_mpa	Mean of Pain Questions
338	d_qol_pa	Pain
339	d_qol_mdy	Mean of Dyspnoea Questions
340	d_qol_dy	Dyspnoea
341	d_qol_msl	Mean of Insomnia Questions
342	d_qol_sl	Insomnia
343	d_qol_map	Mean of Appetite Loss Questions
344	d_qol_ap	Appetite Loss
345	d_qol_mco	Mean of Constipation Questions
346	d_qol_co	Constipation
347	d_qol_mdi	Mean of Diarrhoea Questions
348	d_qol_di	Diarrhoea
349	d_qol_mfi	Mean of Financial difficulties Questions
350	d_qol_fi	Financial difficulties
351	d_qol_mmyds	Mean of Disease symptoms Questions
352	d_qol_myds	Disease Symptoms
353	d_qol_mmyse	Mean of Side Effects of Treatment Questions
354	d_qol_myse	Side effects of treatment
355	d_qol_enr	Enrolled Population
356	sample_type	Either serial (same as previous), BM (bone marrow) baseline, or PB (peripheral blood).
357	specimen_id	An ID for the specimen, of the format [PUBLIC_ID]_[VISIT_ID]_[TISSUE SITE: BM|PB]
--Risk indices--
358	keatsnfkb_index	Jonathan Keats' NF KappaB index, a scalar value positively correlated with risk
359	keatsprolif_index	Jonathan Keats' Proliferation index, a scalar value positively correlated with risk
360	pi_pbl_index	An unknown "PI_PBL" index.
361	uams70_index	UAMS70 index
362	uams70_call	UAMS70 classification. Code 1 = high risk, top 15 percentile in the UAMS70 index, 0 = standard risk, bottom 85 percentile in the UAMS70 index.
363	pi_pbl_call	Unknown "PI_PBL" classification, Code 1 = positive, 0 = negative.
364	ldh_level	LDH-level categorized as High/Normal/Low
--Circulating multiple myeloma cell--
365	cmmc_visit_name	Reason for CMMC appointment e.g., follow up, Screening, Restaging, Baseline, Post-transplant, Remission/Response, Relapse/progression
366	cmmc_comments	Additional remarks left by clinician. Unstructured field.
367	cmmc	Number of circulating multiple myeloma cells detected from blood lab test. A positive integer or zero.
368	cmmc_reasonforproc	Reason for counting the cells e.g., post-transplant, confirm progression, Confirm response, Restaging disease
369	cmmc_bone_specify2	Additional remarks left by clinician. Unstructured field.
370	cmmc_reasoncode	Ignore
371	cmmc_crhit	Complete remission confirmed based on circulating MM cell count.
372	cmmc_pdhit	Progression of disease confirmed based on circulating MM cell count.
373	cmmc_hit	Either complete remission or progression of disease hit.
374	cmmc_recdy	Day relative to diagnosis was the cell count done. A negative number means the test was done prior to diagnosis.
--ignore--
375	enr	Enrolled Population. Ignore as it is always 1 (constant column).
